Baumert; Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Baumert; Thomas.The latest application filed is for "clinical gene signature-based human cell culture model and uses thereof".

Company Profile

6.9.10

Baumert; Thomas - Strasbourg FR
Baumert; Thomas - Freiburg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Humanized anti-claudin-1 antibodies and uses thereof Grant 11,365,251 - Baumert , et al. June 21, 2	2022-06-21
Clinical Gene Signature-Based Human Cell Culture Model and Uses Thereof App 20210309964 - Baumert; Thomas ; et al.	2021-10-07
Clinical gene signature-based human cell culture model and uses thereof Grant 10,988,737 - Baumert , et al. April 27, 2	2021-04-27
Anti-claudin 1 monoclonal antibodies for the prevention and treatment of hepatocellular carcinoma Grant 10,927,170 - Baumert , et al. February 23, 2	2021-02-23
Humanized Anti-Claudin-1 Antibodies and Uses Thereof App 20210040204 - Baumert; Thomas ; et al.	2021-02-11
Humanized anti-claudin-1 antibodies and uses thereof Grant 10,851,160 - Baumert , et al. December 1, 2	2020-12-01
Anti-claudin 1 monoclonal antibodies for the prevention and treatment of hepatocellular carcinoma Grant 10,815,298 - Baumert , et al. October 27, 2	2020-10-27
Humanized Anti-Claudin-1 Antibodies and Uses Thereof App 20190100586 - Baumert; Thomas ; et al.	2019-04-04
Anti-claudin 1 Monoclonal Antibodies For The Prevention And Treatment Of Hepatocellular Carcinoma App 20180258169 - BAUMERT; Thomas ; et al.	2018-09-13
Clinical Gene Signature-based Human Cell Culture Model And Uses Thereof App 20180119096 - BAUMERT; Thomas ; et al.	2018-05-03
Anti-claudin 1 Monoclonal Antibodies For The Prevention And Treatment Of Hepatocellular Carcinoma App 20180057587 - BAUMERT; Thomas ; et al.	2018-03-01
Host cell kinases as targets for antiviral therapies against HCV infection Grant 8,759,010 - Baumert , et al. June 24, 2	2014-06-24
Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis C virus infection Grant 8,518,408 - Baumert , et al. August 27, 2	2013-08-27
Combination Of Anti-envelope Antibodies And Anti-receptor Antibodies For The Treatment And Prevention Of Hcv Infection App 20130129676 - Baumert; Thomas	2013-05-23
Monoclonal Anti-Claudin 1 Antibodies for the Inhibition of Hepatitis C Virus Infection App 20110236347 - Baumert; Thomas ; et al.	2011-09-29
Host Cell Kinases as Targets for Antiviral Therapies Against HCV Infection App 20110229484 - Baumert; Thomas ; et al.	2011-09-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.